Literature DB >> 8163993

Motor neuron disease in a defined English population: estimates of incidence and mortality.

G Dean1, M Quigley, M Goldacre.   

Abstract

Linked statistics from hospital records and death certificates were used to study the incidence of and mortality from motor neuron disease in a defined English population. The incidence of motor neuron disease, measured as first-admission rates for the disease, was studied from 1963 to 1985 and death certificates for the patients admitted to hospital were obtained to the end of 1990. The average annual first-admission rate for motor neuron disease was 2.1/100,000 men (95% confidence interval (CI) 1.9 to 2.4) and 1.7/100,000 women (95% CI 1.5 to 1.9). First-admission rates increased with age and peaked in the age range 65-84 years. Motor neuron disease was recorded on the death certificate for 86% of patients who died while they had the disease and there was no appreciable change over time in the recording of motor neuron disease as the underlying cause of death. The admission and mortality data derive from different sources, hospital statistical abstracts and death certificates respectively, but trends over time in the two data sets were similar. There was an increase in mortality during the period covered by the study, as there has been in mortality from motor neuron disease nationally, and the increase in mortality in the Oxford region was accompanied by an increase in first-admission rates. It is concluded that the increase in mortality from motor neuron disease probably occurred as a result of an increase in the diagnosed incidence of the disease rather than changes in death certification practice.

Entities:  

Mesh:

Year:  1994        PMID: 8163993      PMCID: PMC1072873          DOI: 10.1136/jnnp.57.4.450

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

1.  Rising mortality from motoneuron disease.

Authors:  T P Flaten
Journal:  Lancet       Date:  1989-05-06       Impact factor: 79.321

2.  Longitudinal Gompertzian analysis of ALS mortality in England and Wales, 1963-1989: estimates of susceptibility in the general population.

Authors:  S Neilson; I Robinson; M Hunter
Journal:  Mech Ageing Dev       Date:  1992-06       Impact factor: 5.432

3.  Rising mortality from motoneuron disease in the USA, 1962-84.

Authors:  D E Lilienfeld; E Chan; J Ehland; J Godbold; P J Landrigan; G Marsh; D P Perl
Journal:  Lancet       Date:  1989-04-01       Impact factor: 79.321

Review 4.  Criteria for diagnosis of familial amyotrophic lateral sclerosis. European FALS Collaborative Group.

Authors:  M Swash; N Leigh
Journal:  Neuromuscul Disord       Date:  1992       Impact factor: 4.296

5.  Increasing trend of ALS in France and elsewhere: are the changes real?

Authors:  S Durrleman; A Alperovitch
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

6.  Motor neuron disease in England and Wales, 1959-1979.

Authors:  J Buckley; C Warlow; P Smith; D Hilton-Jones; S Irvine; J R Tew
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

7.  The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland.

Authors:  M Elian; G Dean
Journal:  Neuroepidemiology       Date:  1992       Impact factor: 3.282

  7 in total
  6 in total

Review 1.  Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival.

Authors:  John D Beard; Freya Kamel
Journal:  Epidemiol Rev       Date:  2014-10-31       Impact factor: 6.222

2.  The epidemiology of motor neurone disease in two counties in the southwest of England.

Authors:  Ibrahim Imam; Susan Ball; Dave Wright; C Oliver Hanemann; John Zajicek
Journal:  J Neurol       Date:  2010-01-22       Impact factor: 4.849

3.  Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.

Authors:  Michael J Goldacre; Marie Duncan; Myfanwy Griffith; Martin R Turner
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

4.  Familial clustering of ALS in a population-based resource.

Authors:  Summer B Gibson; Karla P Figueroa; Mark B Bromberg; Stefan-M Pulst; Lisa Cannon-Albright
Journal:  Neurology       Date:  2013-12-04       Impact factor: 9.910

5.  Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease.

Authors:  Karen M Fisher; Boubker Zaaimi; Timothy L Williams; Stuart N Baker; Mark R Baker
Journal:  Brain       Date:  2012-06-22       Impact factor: 13.501

6.  Association of lead exposure with survival in amyotrophic lateral sclerosis.

Authors:  Freya Kamel; David M Umbach; Lillian Stallone; Marie Richards; Howard Hu; Dale P Sandler
Journal:  Environ Health Perspect       Date:  2008-07       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.